Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer’s disease

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics

Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961

β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE

Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876 · cited 1×

Phases of Aβ-deposition in the human brain and its relevance for the development of AD

Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490

Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859

Amyloid β-peptide is produced by cultured cells during normal metabolism

Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921

Purification and cloning of amyloid precursor protein β-secretase from human brain

Sinha, S., Anderson, J. P., Barbour, R., Basi, G. S., Caccavello, R., Davis, D., Doan, M., Dovey, H. F., Frigon, N., Hong, J., et al. (1999) · Nature · doi:10.1038/990114 · Cited by 1,612

A Window into the Heterogeneity of Human Cerebrospinal Fluid Aβ Peptides

Ghidoni, R., Paterlini, A., Albertini, V., Stoppani, E., Binetti, G. G., Fuxé, K., Benussi, L., & Agnati, L. F. (2011) · BioMed Research International · doi:10.1155/2011/697036 · Cited by 15

N-Terminal Truncated Aβ4-42 Is a Substrate for Neprilysin Degradation in vitro and in vivo

Hornung, K. A., Zampar, S., Engel, N., Klafki, H., Liepold, T., Bayer, T. A., Wiltfang, J., Jahn, O., & Wirths, O. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181134 · Cited by 15

Aminoterminally Truncated and Oxidized Amyloid-β Peptides in the Cerebrospinal Fluid of Alzheimer's Disease Patients

Bibl, M., Gallus, M., Welge, V., Esselmann, H., & Wiltfang, J. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111796 · Cited by 15

Is there correlation between Aβ-heme peroxidase activity and the peptide aggregation state? A literature review combined with hypothesis

Khodarahmi‬, R., & Ashrafi-Kooshk, M. R. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.09.074 · Cited by 15

Recent advances in immunotherapy targeting amyloid-beta and tauopathies in Alzheimer’s disease

Sha, S., Ren, L., Xing, X., Guo, W., Wang, Y., Li, Y., Cao, Y., & Qu, L. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00846 · Cited by 16

Direct Competition of ATCUN Peptides with Human Serum Albumin for Copper(II) Ions Determined by LC-ICP MS

Noormägi, A., Golubeva, T., Berntsson, E., Wärmländer, S. K. T. S., Tõugu, V., & Palumaa, P. (2023) · ACS Omega · doi:10.1021/acsomega.3c04649 · Cited by 12

Intermediate Antiparallel β Structure in Amyloid β Plaques Revealed by Infrared Spectroscopic Imaging

Holcombe, B., Foes, A., Banerjee, S., Yeh, K. L., Wang, S. J., Bhargava, R., & Ghosh, A. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00400 · Cited by 13

Identification of isoAsp7-Aβ as a major Aβ variant in Alzheimer’s disease, dementia with Lewy bodies and vascular dementia

Schrempel, S., Kottwitz, A. K., Piechotta, A., Gnoth, K., Büschgens, L., Hartlage‐Rübsamen, M., Morawski, M., Schenk, M., Kleinschmidt, M., Serrano, G. E., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02824-9 · Cited by 14

The Dynamics of β-Amyloid Proteoforms Accumulation in the Brain of a 5xFAD Mouse Model of Alzheimer’s Disease

Bugrova, A. E., Strelnikova, P. A., Indeykina, M. I., Kononikhin, A. S., Zakharova, N. V., Brzhozovskiy, A. G., Barykin, E. P., Игоревич, П. С., Gavrish, M. S., Babaev, A. A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010027 · Cited by 14

Cross-Seeded Fibrillation Induced by Pyroglutamate-3 and Truncated Aβ40 Variants Leads to Aβ40 Structural Polymorphism Modulation and Elevated Toxicity

Hu, Z., Cruceta, L., Zhang, S., Sun, Y. P., & Qiang, W. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00341 · Cited by 14

Amyloid Beta Peptide-Mediated Alterations in Mitochondrial Dynamics and its Implications for Alzheimer’s Disease

Monsalvo-Maraver, L. Á., Maya-López, M., Rangel‐López, E., Túnez, I., Tinkov, A. A., Skalny, A. V., Ferrer, B., Aschner, M., & Santamaría, A. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220616094036 · Cited by 14

Amyloid-β peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer’s disease with APPdup and Down syndrome

Kasri, A., Camporesi, E., Gkanatsiou, E., Boluda, S., Brinkmalm, G., Stimmer, L., Ge, J., Hanrieder, J., Villain, N., Duyckaerts, C. J., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02756-4 · Cited by 16

Mass spectrometry analysis of tau and amyloid‐beta in iPSC‐derived models of Alzheimer’s disease and dementia

Arber, C., Alatza, A., Leckey, C. A., Paterson, R. W., Zetterberg, H., & Wray, S. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15315 · Cited by 13

Immunoprecipitation of Amyloid Fibrils by the Use of an Antibody that Recognizes a Generic Epitope Common to Amyloid Fibrils

Greiner, E. R., Kelly, J. W., & Palhano, F. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105433 · Cited by 13

Functional Amyloids and their Possible Influence on Alzheimer Disease

Lau, A., Bourkas, M. E. C., Lu, Y. Q. Q., Ostrowski, L., Weber‐Adrian, D., Figueiredo, C., Arshad, H., Shoaei, S. Z. S., Morrone, C. D., Matan‐Lithwick, S. A., et al. (2017) · Discoveries · doi:10.15190/d.2017.9 · Cited by 13

Physical activity and cognitive stimulation ameliorate learning and motor deficits in a transgenic mouse model of Alzheimer’s disease

Stazi, M., & Wirths, O. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112951 · Cited by 13

Astrocytic uptake of posttranslationally modified amyloid‐β leads to endolysosomal system disruption and induction of pro‐inflammatory signaling

Wirth, S., Schlößer, A., Beiersdorfer, A., Schweizer, M., Woo, M. S., Friese, M. A., Lohr, C., & Grochowska, K. M. (2024) · Glia · doi:10.1002/glia.24539 · Cited by 12

Amino‐terminally elongated Aβ peptides are generated by the secreted metalloprotease ADAMTS4 and deposit in a subset of Alzheimer's disease brains

Wirths, O., Lehnen, C., Fricke, M., Talucci, I., Klafki, H., Morgado, B., Lehmann, S., Münch, C., Liepold, T., Wiltfang, J., et al. (2024) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12991 · Cited by 14

Plasma pyroglutamate‐modified amyloid beta differentiates amyloid pathology

Wang, P., Lin, K., Liu, H., Andréasson, U., Blennow, K., Zetterberg, H., & Yang, S. (2020) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12029 · Cited by 11

A Combination of Caffeine Supplementation and Enriched Environment in an Alzheimer’s Disease Mouse Model

Stazi, M., Zampar, S., Klafki, H., Meyer, T., & Wirths, O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032155 · Cited by 11

Multiplexing and multivariate analysis in neurodegeneration

Andréasson, U., Portelius, E., Pannee, J., Zetterberg, H., & Blennow, K. (2012) · Methods · doi:10.1016/j.ymeth.2012.02.004 · Cited by 12

Exploration of the Potential Role for Aβ in Delivery of Extracellular Copper to Ctr1

Stefaniak, E., Pushie, M. J., Vaerewyck, C., Corcelli, D., Griggs, C., Lewis, W. C., Kelley, E., Maloney, N., Sendzik, M. R., Bal, W., et al. (2020) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.0c02100 · Cited by 12

Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer’s Disease

Allué, J. A., Sarasa, L., Izco, M., Pérez‐Grijalba, V., Fandos, N., Pascual‐Lucas, M., Ogueta, S., Pesini, P., & Sarasa, M. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160280 · Cited by 13

Rationally Designed Cu(I) Ligand to Prevent CuAβ-Generated ROS Production in the Alzheimer’s Disease Context

Rulmont, C., Stigliani, J., Hureau, C., & Esmieu, C. (2024) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.3c02693 · Cited by 12

Genomic stress and impaired DNA repair in Alzheimer disease

Neven, J., Issayama, L. K., Dewachter, I., & Wilson, D. M. (2024) · DNA repair · doi:10.1016/j.dnarep.2024.103678 · Cited by 12

Distinct Aggregation Behavior of N-Terminally Truncated Aβ4–42 Over Aβ1–42 in the Presence of Zn(II)

Na, C., Kim, M., Kim, G., Lin, Y., Lee, Y., Bal, W., Nam, E., & Lim, M. H. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00831 · Cited by 11

Unraveling the mystery of citrate transporters in Alzheimer’s disease: An updated review

Mukherjee, A. G., Mishra, S., Gopalakrishnan, A. V., Kannampuzha, S., Murali, R., Wanjari, U. R., Stany, B. K., Vellingiri, B., Madhyastha, H., Deepankumar, K., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102726 · Cited by 11

Aβ31–35 Decreases Neprilysin-Mediated Alzheimer’s Amyloid-β Peptide Degradation

Leite, J. P., Lete, M. G., Fowler, S. A., Gimeno, A., Rocha, J. F., Sousa, S. F., Webster, C. I., Jiménez‐Barbero, J., & Gales, L. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00432 · Cited by 11

Matrix Development for the Detection of Phosphorylated Amyloid-β Peptides by MALDI-TOF-MS

Liepold, T., Klafki, H., Kumar, S., Walter, J., Wirths, O., Wiltfang, J., & Jahn, O. (2023) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.2c00270 · Cited by 12

Unveiling Brain Aβ Heterogeneity Through Targeted Proteomic Analysis

Rostagno, A. A., Neubert, T. A., & Ghiso, J. A. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7816-8_3 · Cited by 11

A Modification-Specific Peptide-Based immunization Approach Using CRM197 Carrier Protein: Development of a Selective Vaccine Against Pyroglutamate Aβ Peptides

Vingtdeux, V., Zhao, H., Chandakkar, P., Acker, C. M., Davies, P., & Marambaud, P. (2016) · Molecular Medicine · doi:10.2119/molmed.2016.00218 · Cited by 11

N-Terminally Truncated Aß Peptide Variants in Alzheimer’s Disease

Wirths, O., Zampar, S., & Weggen, S. (2019) · Codon Publications eBooks · doi:10.15586/alzheimersdisease.2019.ch7 · Cited by 13

Anti-Parallel β-Hairpin Structure in Soluble Aβ Oligomers of Aβ40-Dutch and Aβ40-Iowa

Fu, Z., Nostrand, W. E. V., & Smith, S. O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031225 · Cited by 11

Blood‐brain barrier dysfunction and reduced cerebrospinal fluid levels of soluble amyloid precursor protein‐β in patients with subcortical small‐vessel disease

Kettunen, P., Bjerke, M., Eckerström, C., Jonsson, M. A. G., Zetterberg, H., Blennow, K., Svensson, J., & Wallin, A. (2022) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12296 · Cited by 11

A Copper-Binding Peptide with Therapeutic Potential against Alzheimer′s Disease: From the Blood–Brain Barrier to Metal Competition

López-Guerrero, V. E., Posadas, Y., Sánchez‐López, C., Smart, A., Miranda, J., Singewald, K., Bandala, Y., Juaristi, E., Auwer, C. D., Perez‐Cruz, C., et al. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00796 · Cited by 10

Colocalization of β-Sheets and Carotenoids in Aβ Plaques Revealed with Multimodal Spatially Resolved Vibrational Spectroscopy

de Oliveira, A. P., Chase, W., Confer, M. P., Walker, S., Baghel, D., & Ghosh, A. (2023) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.3c04782 · Cited by 10

Mirror Image of the Amyloid-β Species in CerebrospinalFluid and Cerebral Amyloid in Alzheimer’s Disease

Catania, M., Fede, G. D., Tonoli, E., Benussi, L., Pasquali, C., Giaccone, G., Maderna, E., Ghidoni, R., & Tagliavini, F. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150179 · Cited by 10

AβPP processing results in greater toxicity per amount of Aβ1-42 than individually expressed and secreted Aβ1-42 inDrosophila melanogaster

Bergkvist, L., Sandin, L., Kågedal, K., & Brorsson, A. (2016) · Biology Open · doi:10.1242/bio.017194 · Cited by 10

Stoichiometry of Heavy Metal Binding to Peptides Involved in Alzheimer’s Disease: Mass Spectrometric Evidence

Jureschi, M., Lupăescu, A.-V., Ion, L., Petre, B. A., & Drochioiu, G. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-15950-4_23 · Cited by 10

Rapid Generation of Dityrosine Cross-linked Aβ Oligomers via Cu-Redox Cycling

Gunn, A. P., Roberts, B. R., & Bush, A. I. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-551-0_1 · Cited by 10

Oxidase Reactivity of CuII Bound to N-Truncated Aβ Peptides Promoted by Dopamine

Bacchella, C., Dell’Acqua, S., Nicolis, S., Monzani, E., & Casella, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105190 · Cited by 9

Dual mode of voltammetric studies on Cu( ii ) complexes of His2 peptides: phosphate and peptide sequence recognition

Tobolska, A., Głowacz, K., Ciosek, P., Bal, W., Wróblewski, W., & Wezynfeld, N. E. (2022) · Dalton Transactions · doi:10.1039/d2dt03078k · Cited by 9

The effect of histidine, histamine, and imidazole on electrochemical properties of Cu( ii ) complexes of Aβ peptides containing His-2 and His-3 motifs

Tobolska, A., Jabłońska, A., Suwińska, A., Wawrzyniak, U. E., Wróblewski, W., & Wezynfeld, N. E. (2024) · Dalton Transactions · doi:10.1039/d4dt01354a · Cited by 9

Recent advances in the modulation of amyloid protein aggregation using the supramolecular host-guest approaches

Maity, D. (2023) · Biophysical Chemistry · doi:10.1016/j.bpc.2023.107022 · Cited by 9

Novel Vaccine against Pathological Pyroglutamate-Modified Amyloid Beta for Prevention of Alzheimer’s Disease

Zagorski, K., King, O., Hovakimyan, A., Petrushina, I., Antonyan, T., Chailyan, G., Ghazaryan, M., Hyrc, K. L., Chadarevian, J. P., Davtyan, H., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129797 · Cited by 8

Pyroglutamate-Amyloid-β and Glutaminyl Cyclase Are Colocalized with Amyloid-β in Secretory Vesicles and Undergo Activity-Dependent, Regulated Secretion

Cynis, H., Funkelstein, L., Toneff, T., Mosier, C., Ziegler, M. G., Koch, B., Demuth, H., & HOOK, V. Y. H. (2014) · Neurodegenerative Diseases · doi:10.1159/000358430 · Cited by 8

On the ability of CuAβ1-x peptides to form ternary complexes: Neurotransmitter glutamate is a competitor while not a ternary partner

Frączyk, T., Zawisza, I. A., Goch, W., Stefaniak, E., Drew, S. C., & Bal, W. (2016) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2016.02.035 · Cited by 9

γ-Secretase modulation inhibits amyloid plaque formation and growth and stimulates plaque regression in amyloid precursor protein/presenilin-1 mice

Nordvall, G., Yan, P., Agholme, L., Lundkvist, J., Sandin, J., Biverstål, H., Winblad, B. G., Zetterberg, H., Klintenberg, R., Ferm, M. T., et al. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103400 · Cited by 8

Small RNA Sequencing in the Tg4–42 Mouse Model Suggests the Involvement of snoRNAs in the Etiology of Alzheimer’s Disease

Lio, C. T., Kacprowski, T., Klaedtke, M., Jensen, L. R., Bouter, Y., Bayer, T. A., & Kuss, A. W. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220110 · Cited by 7

Solid-phase synthesis and pathological evaluation of pyroglutamate amyloid-β3-42 peptide

Cho, I., Lee, H., Lee, D.-H., Park, I. W., Yoon, S., Kim, H. Y., & Kim, Y. S. (2023) · Scientific Reports · doi:10.1038/s41598-022-26616-x · Cited by 7

Aggregation Dynamics Characteristics of Seven Different Aβ Oligomeric Isoforms-Dependence on the Interfacial Interaction

Guan, Y., Li, Y., Gao, W., Mei, J., Xu, W. W., Wang, C., & Ai, H. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00585 · Cited by 7

Chemical Strategies to Modulate Amyloidogenesis Associated with Neurodegenerative Diseases

Na, C., Jang, Y., Son, M., & Lim, M. H. (2026) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c20362 · Cited by 6

Amyloid β Proteoforms Elucidated by Quantitative LC/MS in the 5xFAD Mouse Model of Alzheimer’s Disease

Kandi, S., Cline, E. N., Rivera, B. M., Viola, K. L., Zhu, J., Condello, C., LeDuc, R. D., Klein, W. L., Kelleher, N. L., & Patrie, S. M. (2023) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00353 · Cited by 6

Hemin, copper and amyloid-β: A medley involved in Alzheimer's disease. An interaction that fine regulates the reactivity

Bacchella, C., Caro, S. D., Nicolis, S., Monzani, E., & Dell’Acqua, S. (2024) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2024.112775 · Cited by 7

Magnetic Levitational Assembly of Differentiated SH‐SY5Y Cells for Aβ‐Induced 3D Alzheimer's Disease Modeling and Curcumin Screening

Bilginer-Kartal, R., & Yıldız, A. A. (2025) · Macromolecular Bioscience · doi:10.1002/mabi.202400658 · Cited by 6

Influence of the familial Alzheimer's disease–associated T43I mutation on the transmembrane structure and γ-secretase processing of the C99 peptide

Tang, T.-C., Kienlen‐Campard, P., Hu, Y., Perrin, F., Opsomer, R., Octave, J., Constantinescu, S. N., & Smith, S. O. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006061 · Cited by 7

Resistance of Cu(Aβ4–16) to Copper Capture by Metallothionein‐3 Supports a Function for the Aβ4–42 Peptide as a Synaptic CuII Scavenger

Wezynfeld, N. E., Stefaniak, E., Stachucy, K., Drozd, A., Płonka, D., Drew, S. C., Krężel, A., & Bal, W. (2016) · Angewandte Chemie · doi:10.1002/ange.201511968 · Cited by 6

Targeting the Pathological Hallmarks of Alzheimer’s Disease Through Nanovesicleaided Drug Delivery Approach

Roy, R., Bhattacharya, P., & Borah, A. (2022) · Current Drug Metabolism · doi:10.2174/1389200223666220526094802 · Cited by 6

Cu(II) Binding to the N-Terminal Model Peptide of the Human Ctr2 Transporter at Lysosomal and Extracellular pH

Wezynfeld, N. E., Vileno, B., & Faller, P. (2019) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.9b00711 · Cited by 7

The Palladium(II) Complex of Aβ4−16 as Suitable Model for Structural Studies of Biorelevant Copper(II) Complexes of N-Truncated Beta-Amyloids

Mital, M., Szutkowski, K., Bossak‐Ahmad, K., Skrobecki, P., Drew, S. C., Poznański, J. T., Zhukov, I., Frączyk, T., & Bal, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239200 · Cited by 6

Effect of astaxanthin in type-2 diabetes -induced APPxhQC transgenic and NTG mice

Babalola, J. A., Stracke, A., Loeffler, T., Schilcher, I., Sideromenos, S., Flunkert, S., Neddens, J., Lignell, Å., Prokesch, M., Pazenboeck, U., et al. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.101959 · Cited by 5

Isomerized Aβ in the brain can distinguish the status of amyloidosis in the Alzheimer’s disease spectrum

Mukherjee, S., Coyle, R. A., Dubois, C., Perez, K. A., McLean, C., Masters, C. L., & Roberts, B. R. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02914-2 · Cited by 5

The role of d-block metal ions in neurodegenerative diseases

Posadas, Y., López-Guerrero, V. E., Arcos‐López, T., Sayler, R. I., Sánchez‐López, C., Segovia, J., Perez‐Cruz, C., & Quintanar, L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823144-9.00115-1 · Cited by 5

Diversity of amyloid beta peptide actions

Mardanyan, S. S., Sharoyan, S. G., & Antonyan, A. A. (2024) · Reviews in the Neurosciences · doi:10.1515/revneuro-2023-0100 · Cited by 5

Quantum dots-based “chemical tongue” for the discrimination of short-length Aβ peptides

Głowacz, K., Drozd, M., Tokarska, W., Wezynfeld, N. E., & Ciosek, P. (2024) · Microchimica Acta · doi:10.1007/s00604-023-06115-0 · Cited by 5

The contribution of N-terminally modified amyloid beta to the etiology of Alzheimer's disease

Wittnam, J. L. (2012) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3182 · Cited by 5

The role of amyloid beta 4-42 in the etiology of Alzheimer's disease

Bouter, Y. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-4849 · Cited by 5

Oxidative Activity of Copper Ions in Ternary Systems With N‐Truncated Amyloid Beta Peptides and Low Molecular Weight Substances

Sudzik, D., Bal, W., & Wezynfeld, N. E. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70145 · Cited by 5

Post‐Translational Modifications Distinguish Amyloid‐β Isoforms in Cerebral Amyloid Angiopathy and Alzheimer's Disease

Koutarapu, S., Roberts, K. F., Coyle, R. A., Mehla, J., Sato, C., Zipfel, G. J., Bateman, R. J., Schwetye, K. E., & Mukherjee, S. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70335 · Cited by 4

Coptisine reverses Alzheimer’s disease by targeting cholinergic and amyloidogenic pathways

Roy, A., Roy, R., Meena, B. S., Kumar, D., Bhattacharya, P., Gahatraj, I., Chhetry, S., & Borah, A. (2024) · Medical Hypotheses · doi:10.1016/j.mehy.2024.111407 · Cited by 4

Immunotherapy Against N-Truncated Amyloid-β Oligomers

Bayer, T. A., & Wirths, O. (2016) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-3560-4_3 · Cited by 4

A Question of Origins: Non-neuronal Sources of Amyloid-β

Sasmita, A. O., & Depp, C. (2026) · Neuroscience Bulletin · doi:10.1007/s12264-025-01572-4 · Cited by 4

Investigating Cu(I) binding to model peptides of N-terminal Aβ isoforms

Hjelmstad, A. S., Pushie, M. J., Ruth, K., Escobedo, M., Kuter, K. E., & Haas, K. L. (2024) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2024.112480 · Cited by 3

Plasma amyloid-β precursor protein 669–711/amyloid-β1–42 ratio is associated with cognition in Alzheimer's disease

Noguchi‐Shinohara, M., Sakashita, Y., Nakano, H., Muramatsu, D., Hikishima, S., Komatsu, J., Murakami, H., Mori, Y., & Ono, K. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2024.100003 · Cited by 3

Cortical Gray Matter Proteins Associated With Cerebral Amyloid Angiopathy in Community-Dwelling Older Adults

Oveisgharan, S., Yu, L., Yang, J., Agrawal, S., Vialle, R. A., Lopes, K. D. P., Tasaki, S., Wang, Y., Petyuk, V., Young‐Pearse, T. L., et al. (2025) · Neurology · doi:10.1212/wnl.0000000000214024 · Cited by 3

SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer’s disease

Brunner, D., Flunkert, S., Neddens, J., Duller, S., Scopes, D. I. C., Treherne, J. M., & Hutter‐Paier, B. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.09.028 · Cited by 3

Tuning multispectral fluorescence quantum dot–based identification of short-length amyloid β peptides by applying Cu(II) ions

Głowacz, K., Tokarska, W., Olechowska, A., Wezynfeld, N., & Ciosek-Skibińska, P. (2024) · Microchimica Acta · doi:10.1007/s00604-024-06764-9 · Cited by 3

Disaggregation of Aβ42 for Structural and Biochemical Studies

Chung, H., Crooks, E. J., Ziliox, M., & Smith, S. O. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7811-3_20 · Cited by 3

Effect of Meroterpenoids from Sargassum macrocarpum on the Inhibition of Amyloid Polypeptide Aggregation

Tozawa, Y., Shinoda, S., Sekiguchi, M., Miyamae, Y., & Shigemori, H. (2024) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b24-00610 · Cited by 2

Chronic exposure to a synthetic cannabinoid improves cognition and increases locomotor activity in Tg4-42 Alzheimer's disease mice

Ott, F. W., Sichler, M. E., Bouter, C., Enayati, M., Wiltfang, J., Bayer, T. A., Beindorff, N., Löw, M. J., & Bouter, Y. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823241306770 · Cited by 2

Alzheimer’s Disease and Other Neurodegenerative Disorders

Rosén, C., Zetterberg, H., & Blennow, K. (2015) · Springer eBooks · doi:10.1007/978-3-319-01225-4_20 · Cited by 2

Biomarkers of Alzheimer’s disease

Pitt, J. E. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-404630-6.00048-8 · Cited by 2

Development of Kinase Inactive PD173955 Analogues for Reducing Production of Aβ Peptides

Sinha, A., Gindinova, K., Mui, E., Netzer, W. J., & Sinha, S. C. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00213 · Cited by 2

Neglected N-Truncated Amyloid-β Peptide and Its Mixed Cu–Zn Complexes

Frączyk, T., & Cieplak, P. (2022) · The Protein Journal · doi:10.1007/s10930-022-10056-7 · Cited by 2

Pyroglutamylation modulates electronic properties and the conformational ensemble of the amyloid β‐peptide

Davidson, D. S., & Lemkul, J. A. (2024) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26677 · Cited by 2

Unresolved Questions in Alzheimer's Research: Will Biomarkers Help?

Zetterberg, H. (2013) · Biomarkers in Medicine · doi:10.2217/bmm.13.120 · Cited by 2

The Features of Beta-Amyloid Phosphorylation in Alzheimer’s Disease

Strelnikova, P. A., Бугрова, А. Е., Zakharova, N. V., Danichkina, K. V., Indeykina, M. I., Gavrish, M. S., Krut’, V. G., Babaev, A. A., Morozova, A. Y., Kononikhin, A. S., et al. (2024) · Acta Naturae · doi:10.32607/actanaturae.27456 · Cited by 1

Electrochemical Fingerprinting for Discrimination of $\mathrm{A}\beta_{3-16}, \mathrm{A}\beta_{11-16}$ and their Pyroglutamate Counterparts, Related to Alzheimer's Disease

Tobolska, A., Biernat, K., Wezynfeld, N. E., Wróblewski, W., & Ciosek, P. (2024) · Proceedings of IEEE Sensors/Proceedings of IEEE Sensors ... · doi:10.1109/sensors60989.2024.10784537 · Cited by 1

Ion-Mediated Adsorption of Amyloid-β Peptides at the Liquid/Liquid Interface: Insights from Electrochemistry and Molecular Dynamics Simulations

Holzinger, A., Bhattacharya, S., Wiloch, M. Z., & Jönsson‐Niedziółka, M. (2026) · ACS electrochemistry. · doi:10.1021/acselectrochem.5c00358 · Cited by 1

MALDI mass spectrometry imaging (MSI) reveals molecular and structural heterogeneity of amyloid-β in sporadic Alzheimer’s disease and Down syndrome

Minta, K., Söderberg, L., Gkanatsiou, E., Johannesson, M., Möller, C., Björklund, M., Osswald, G., Lannfelt, L., Fabre, S. F., & Michno, W. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02280-4 · Cited by 1

Proteomics in the Diagnosis of Inborn Encephalopathies of Unknown Origin: A Myth or Reality

Kupniewska, A., Szymańska, K., & Demkow, U. A. (2017) · Advances in experimental medicine and biology · doi:10.1007/5584_2017_104 · Cited by 1

The Risk Factors and Causes for Alzheimer’s Disease

Zhang, Y. (2022) · Advances in Social Science, Education and Humanities Research/Advances in social science, education and humanities research · doi:10.2991/assehr.k.220504.160 · Cited by 1

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Ikegawa, M., Nirasawa, T., Kakuda, N., Miyasaka, T., Kuzuhara, Y., Murayama, S., & Ihara, Y. (2019) · Journal of Visualized Experiments · doi:10.3791/57645-v · Cited by 1

Modulation of Aβ 1–40 and Aβ 4–40 co-assembly by zinc: getting closer to the biological reality

de Cremoux, L., Falcone, E., Schmitt, D. A., Stefaniak, E., Wiśniewska, M., Vitale, N., Bal, W., & Hureau, C. (2025) · Inorganic Chemistry Frontiers · doi:10.1039/d5qi00850f · Cited by 2

Quantitative Mass Spectrometric Assay of Whole and CNBr-Cleaved Amyloid-β Peptides in Human Brain

Furman, R., Ng, S. C. W., Komatsu, H., & Axelsen, P. H. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-190647 · Cited by 1

Yeast as a Model for Studying Aβ Aggregation, Toxicity and Clearance

Bharadwaj, P. (2011) · Australasian Journal of Paramedicine · Cited by 1

Distinct aggregation and toxicity of N-terminally truncated Abeta4-42 over Abeta1-42 in the presence of Zn(II)Preprint

Na, C., Kim, G., Bal, W., Nam, E., & Lim, M. H. (2023) · ChemRxiv · doi:10.26434/chemrxiv-2023-061jk

SINGLE-MOLECULE ANALYSIS OF ALZHEIMER'S β-PEPTIDE OLIGOMER DISASSEMBLY AT PHYSIOLOGICAL CONCENTRATION

Chen, C. (2014) · UKnowledge (University of Kentucky)

Influence of genetic variability and external regulating factors on amyloid-beta peptide aggregation

Hubin, E. (2014) · doi:10.3990/1.9789036537643

Structural and Toxic Properties of Protein Aggregates: Towards a Molecular Understanding of Alzheimer's Disease

Wang, L., & Campioni, S. (2011) · InTech eBooks · doi:10.5772/20922

The Pathogenic Ab43 Is Enriched in Familial and Sporadic Alzheimer Disease

Anna, S., Wel, H., Winblad, B., Graff, C., & Tjernberg, L. O. (2012)

The Pathogenic Aβ43 Is Enriched in Familial and Sporadic Alzheimer Disease

Matton, A., Welander, H., Winblad, B. G., Graff, C., & Tjernberg, L. O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055847 · Cited by 69

Distribution of isomerized and racemized amyloid β isoforms in sporadic Alzheimer’s disease using ion‐mobility mass spectrometry

Mukherjee, S., Perez, K. A., Lago, L., Klatt, S., Birchall, I. E., Barnham, K. J., Masters, C. L., & Roberts, B. R. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.039256

Distinct cerebrospinal fluid amyloid β peptide signatures in sporadic and PSEN1A431E-associated familial Alzheimer's disease

Portelius, E., Andréasson, U., Ringman, J. M., Büerger, K., Daborg, J., Buchhave, P., Hansson, O., Harmsen, A., Gustavsson, M. K., Hanse, E., et al. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-2 · Cited by 94

Isomerized Aβ in the brains can distinguish the status of amyloidosis in the Alzheimer’s Disease continuum

Mukherjee, S., Dubois, C., Perez, K. A., Birchall, I. E., Hinton, F., McLean, C. A., Masters, C. L., & Roberts, B. R. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.090569